{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T09:15:44Z","timestamp":1778404544477,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.reprotox.2022.10.005","type":"journal-article","created":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T21:49:59Z","timestamp":1666820999000},"page":"57-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Embryo-fetal exposure and developmental outcome of lenalidomide following oral administration to pregnant cynomolgus monkeys"],"prefix":"10.1016","volume":"114","author":[{"given":"Julia Y.","family":"Hui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antje","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gondi","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reprotox.2022.10.005_bib1","series-title":"Dark Remedy: The Impact of Thalidomide and Its Revival As A Vital Medicine","author":"Brynner","year":"2001"},{"key":"10.1016\/j.reprotox.2022.10.005_bib2","series-title":"Revlimid: Highlights of Prescribing Information","author":"Celgene Corporation","year":"2019"},{"issue":"9","key":"10.1016\/j.reprotox.2022.10.005_bib3","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nsmb.2874","article-title":"Structure of the human Cereblon\u2013DDB1\u2013lenalidomide complex reveals basis for responsiveness to thalidomide analogs","volume":"21","author":"Chamberlain","year":"2014","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"2","key":"10.1016\/j.reprotox.2022.10.005_bib4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s40262-016-0432-1","article-title":"Clinical pharmacokinetics and pharmacodynamics of lenalidomide","volume":"56","author":"Chen","year":"2016","journal-title":"Clin. Pharmacokinet."},{"issue":"3","key":"10.1016\/j.reprotox.2022.10.005_bib5","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/bdrb.20115","article-title":"Evaluation of the developmental toxicity of lenalidomide in rabbits","volume":"80","author":"Christian","year":"2007","journal-title":"Birth Defects Res. Part B: Dev. Reprod. Toxicol."},{"issue":"Sep","key":"10.1016\/j.reprotox.2022.10.005_bib6","first-page":"223","article-title":"The use of thalidomide as a teratogenic agent in rabbits. Bull","volume":"115","author":"Dekker","year":"1964","journal-title":"Johns. Hopkins Hosp."},{"key":"10.1016\/j.reprotox.2022.10.005_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.38430","article-title":"Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray syndrome","volume":"7","author":"Donovan","year":"2018","journal-title":"ELife"},{"issue":"2","key":"10.1016\/j.reprotox.2022.10.005_bib8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0041-008X(65)90086-4","article-title":"Effects of thalidomide on fetal development in rabbits and on establishment of pregnancy in monkeys","volume":"7","author":"Drobeck","year":"1965","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"2","key":"10.1016\/j.reprotox.2022.10.005_bib9","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/path.1700910227","article-title":"The teratogenic activity of thalidomide in the rabbit","volume":"91","author":"Fabro","year":"1966","journal-title":"J. Pathol. Bacteriol."},{"issue":"7512","key":"10.1016\/j.reprotox.2022.10.005_bib10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nature13527","article-title":"Structure of the DDB1\u2013CRBN E3 ubiquitin ligase in complex with thalidomide","volume":"512","author":"Fischer","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.reprotox.2022.10.005_bib11","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/0041-008X(65)90095-5","article-title":"Teratogenic effects of thalidomide in rabbits, rats, hamsters, and mice","volume":"7","author":"Fratta","year":"1965","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"6","key":"10.1016\/j.reprotox.2022.10.005_bib12","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/bjh.12708","article-title":"Immunomodulatory agents lenalidomide and pomalidomide co\u2010stimulate T cells by inducing degradation of T cell repressors I karos and A iolos via modulation of the E 3 ubiquitin ligase complex CRL 4 CRBN","volume":"164","author":"Gandhi","year":"2013","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.reprotox.2022.10.005_bib13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1530\/jrf.0.0080059","article-title":"Effects of thalidomide on pregnancy in the rabbit","volume":"8","author":"Hay","year":"1964","journal-title":"Reproduction"},{"issue":"5","key":"10.1016\/j.reprotox.2022.10.005_bib14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1159\/000460334","article-title":"The sensitive period and malformation syndrome produced by thalidomide in the crab-eating monkey (Macaca fascicularis)","volume":"2","author":"Hendrickx","year":"1973","journal-title":"J. Med. Primatol."},{"issue":"2","key":"10.1016\/j.reprotox.2022.10.005_bib15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/tera.1420070206","article-title":"Appendicular skeletal and visceral malformations induced by thalidomide in bonnet monkeys","volume":"7","author":"Hendrickx","year":"1973","journal-title":"Teratology"},{"issue":"5971","key":"10.1016\/j.reprotox.2022.10.005_bib16","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1126\/science.1177319","article-title":"Identification of a primary target of thalidomide teratogenicity","volume":"327","author":"Ito","year":"2010","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.reprotox.2022.10.005_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/toxsci\/1.1.13","article-title":"Common fetal aberrations and their teratologic significance: a review","volume":"1","author":"Khera","year":"1981","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.reprotox.2022.10.005_bib18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/tera.1420310115","article-title":"Maternal toxicity: a possible etiological factor in embryo-fetal deaths and fetal malformations of rodent-rabbit species","volume":"31","author":"Khera","year":"1985","journal-title":"Teratology"},{"issue":"6168","key":"10.1016\/j.reprotox.2022.10.005_bib19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1126\/science.1244851","article-title":"Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells","volume":"343","author":"Kronke","year":"2013","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.reprotox.2022.10.005_bib20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/tera.1420380303","article-title":"A short history of thalidomide embryopathy","volume":"38","author":"Lenz","year":"1988","journal-title":"Teratology"},{"issue":"6168","key":"10.1016\/j.reprotox.2022.10.005_bib21","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1126\/science.1244917","article-title":"The myeloma drug lenalidomide promotes the cereblon-dependent destruction of ikaros proteins","volume":"343","author":"Lu","year":"2013","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.reprotox.2022.10.005_bib22","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/s41589-018-0129-x","article-title":"SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrate","volume":"14","author":"Matyskiela","year":"2018","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.reprotox.2022.10.005_bib23","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/(SICI)1096-9926(199911)60:5<306::AID-TERA11>3.0.CO;2-Y","article-title":"Teratogen update: thalidomide: a review, with a focus on ocular findings and new potential uses","volume":"60","author":"Miller","year":"1999","journal-title":"Teratology"},{"key":"10.1016\/j.reprotox.2022.10.005_bib24","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0022-3565(25)27910-1","article-title":"A comparison of the teratogenic activity of thalidomide in rabbits and rats","author":"Schumacher","year":"1968","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623822001551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623822001551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:59:32Z","timestamp":1760191172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890623822001551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":24,"alternative-id":["S0890623822001551"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2022.10.005","relation":{},"ISSN":["0890-6238"],"issn-type":[{"value":"0890-6238","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Embryo-fetal exposure and developmental outcome of lenalidomide following oral administration to pregnant cynomolgus monkeys","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2022.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}